Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
KCI, a subsidiary of Samyang Group, won 'Platinum Medal' in EcoVadis ESG Rating, Ranked in the Top 1% worldwide
2024-03-04 21:30
Henlius Forecasts Profit in 2023: Achieving first full year of profitability, and ushering in a new phase of high-quality development
2024-03-04 21:19
Milliken & Company Recognized Among the 2024 World's Most Ethical Companies®
2024-03-04 21:00
Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management
2024-03-04 20:00
Landmark Clinical Approval for YOLT-201 Obtained by the NMPA
2024-03-04 20:00
Hybribio Calls for Raising International HPV Awareness
2024-03-04 18:47
Results from the Clinical Trial of Qilu Pharmaceutical's Novel Anticancer Agent Iparomlimab and Tuvonralimab (QL1706) Featured in Oral Presentation at the ESGO Annual Meeting
2024-03-04 16:53
Caliway Announced Orphan Drug Designation Granted to CBL-514 for the Treatment of Dercum's Disease
2024-03-04 16:22
THAILAND EXPECTS 25% GROWTH IN FITNESS AND MASS PARTICIPATION SPORTS FOR 2024
2024-03-04 09:00
Caliway Announced Orphan Drug Designation Granted to CBL-514 for the Treatment of Dercum's Disease
2024-03-04 07:00
Mezzion Pharmaceuticals Announces Dr. Rahul Rathod of Boston Children's Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2
2024-03-02 10:26
The 16th Zhang Zhongjing Medicine Culture Festival & Forum on High-quality Development of TCM Takes Place in Nanyang, China
2024-03-02 05:10
LIFE FITNESS ANNOUNCES PROMOTION OF ANDREW MAHADEVAN TO CHIEF COMMERCIAL OFFICER TO LEAD CONTINUED GROWTH
2024-03-02 02:00
NMPA Approves the NDA for CARsgen's BCMA CAR-T Therapy Zevorcabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma
2024-03-01 21:50
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories
2024-03-01 21:35
111 to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results- Conference Call to Follow
2024-03-01 17:00
Jacobio Pharma Receives IND Approval for P53 Y220C Activator JAB-30300 in the U.S.
2024-03-01 14:55
Thermo Fisher Scientific to Inaugurate New Office, Marking Milestone Expansion in Indonesia
2024-03-01 10:30
Innovent Announces First Participant Dosed in a Phase I Study of IBI3002 (an anti-IL-4Rα/TSLP bispecific antibody) in Australia
2024-03-01 08:00
'An Urgent Public Health Necessity' - National Institute for Play Releases New Report Underlining Science and Power of Play
2024-03-01 06:20
1
32
33
34
35
36
1531